These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21034788)

  • 1. Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.
    Lee JH; Agacinski G; Williams JH; Wilcock GK; Esiri MM; Francis PT; Wong PT; Chen CP; Lai MK
    Neurochem Int; 2010 Dec; 57(8):985-9. PubMed ID: 21034788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
    Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
    J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias.
    Sheng Y; Lee JH; Medhurst AD; Wilcock GK; Esiri M; Wong PT; Chen CP; Lai MK
    J Neurol Sci; 2012 Apr; 315(1-2):110-4. PubMed ID: 22129936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients.
    Solas M; Francis PT; Franco R; Ramirez MJ
    Neurobiol Aging; 2013 Mar; 34(3):805-8. PubMed ID: 22763024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.
    Kalaria RN; Andorn AC; Harik SI
    Prog Clin Biol Res; 1989; 317():367-74. PubMed ID: 2557637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
    Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.
    Tsang SW; Keene J; Hope T; Spence I; Francis PT; Wong PT; Chen CP; Lai MK
    J Neurol Sci; 2010 Jan; 288(1-2):151-5. PubMed ID: 19818455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD; Weinstein DA; Mash DC
    Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.
    Eggan SM; Lewis DA
    Cereb Cortex; 2007 Jan; 17(1):175-91. PubMed ID: 16467563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.
    Zurolo E; Iyer AM; Spliet WG; Van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 Sep; 170(1):28-41. PubMed ID: 20621164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: a comparison between the gray mouse lemur (Microcebus murinus, primates) and rat.
    Harkany T; Dobszay MB; Cayetanot F; Härtig W; Siegemund T; Aujard F; Mackie K
    Neuroscience; 2005; 135(2):595-609. PubMed ID: 16129564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.
    Garcia-Alloza M; Tsang SW; Gil-Bea FJ; Francis PT; Lai MK; Marcos B; Chen CP; Ramirez MJ
    Neurobiol Aging; 2006 Aug; 27(8):1110-7. PubMed ID: 15996794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease.
    Talarico G; Trebbastoni A; Bruno G; de Lena C
    Curr Neuropharmacol; 2019; 17(2):176-183. PubMed ID: 29962346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.